Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Sarcoma 19Genitourinary 4Dermatologic 3CNS 3Thoracic 2Lymphoid 2Gastrointestinal 2Plasma cell 1Breast 1

Conditions

Melanoma 33Carcinoma, Non-Small-Cell Lung 6Uveal Melanoma 5Skin Neoplasms 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 4Kidney Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Mycosis Fungoides 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urticaria Pigmentosa 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Pruritus 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 16pembrolizumab 14Radiosurgery 7Nivolumab 5Celecoxib 5poly ICLC 4Radiation 4Injections 4Radiotherapy 3Melphalan 3Ipilimumab 3Filgrastim 3Etoposide 3Docetaxel 3Cryosurgery 3Blood Specimen Collection 3Biopsy 3130-nm albumin-bound paclitaxel 3trastuzumab deruxtecan 2tislelizumab 2talimogene laherparepvec 2spartalizumab 2fludarabine phosphate 2fludarabine 2durvalumab 2cemiplimab 2atezolizumab 2aldesleukin 2Transurethral Resection of Prostate 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Sarcoma × Blood Specimen Collection × Dermatologic × Clear all
NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Mayo Clinic

Terminated
13 enrolled
DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

NCT01528774 2017-07-26

CTC

Comprehensive Cancer Centers of Nevada

Completed
150 enrolled
DermatologicGenitourinarySarcoma

Kidney Neoplasms, Melanoma, Neoplastic Cells, Circulating, Prostatic Neoplasms, Sarcoma, Somatostatinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡